Fluconazole-sirolimus drug interaction [1]

Transplantation

Volumn 74, Issue 10, 2002, Pages 1477-1478

  Cervelli, Matthew J ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; CARVEDILOL; CYCLOSPORIN; FLUCONAZOLE; ISOSORBIDE DINITRATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIFEDIPINE; PREDNISOLONE; RANITIDINE; RAPAMYCIN;

ADULT; CANDIDIASIS; CASE REPORT; CLINICAL FEATURE; DRUG BLOOD LEVEL; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LETTER; MALE; PRIORITY JOURNAL;

EID: 0036853114     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200211270-00024     Document Type: Letter

References (3)

1. Wyeth Laboratories. Rapamune: Current Approved Prescribing Information. Collegeville, PA, Wyeth-Ayerst Pharmaceuticals 2002.
2. Floren LC, Christians U, Zimmerman JJ, et al. Sirolimus oral bioavailability increases ten-fold with concomitant ketoconazole [abstract]. Am Soc Clin Pharmacol Ther 1999; 65(2): 159.
3. Albengres E, Louet HL, Tillement JP. Systemic antifungal agents, drug interactions of clinical significance. Drug Saf 1998; 18(2)83: 97.